(Q36794824)

16 August 2017

1 reference

title

Pain management, supportive and palliative care in patients with renal cell carcinoma (English)

1 reference

16 August 2017

0 references

Jeffrey S Turner

1

1 reference

16 August 2017

Eric M Cheung

series ordinal

2

1 reference

16 August 2017

Jaya George

series ordinal

3

1 reference

16 August 2017

David I Quinn

series ordinal

4

1 reference

16 August 2017

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

99

1 reference

16 August 2017

issue

5 Pt B

1 reference

16 August 2017

page(s)

1305-1312

1 reference

Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Megestrol acetate in patients with AIDS and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Human renal carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Neurophysiological studies of thin myelinated (A delta) and unmyelinated (C) fibers: application to peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Malignant bone pain: pathophysiology and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

A visceral pain pathway in the dorsal column of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Pathobiology of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Practice guidelines for transdermal opioids in malignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Morphine in cancer pain management: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Advances in opioid therapy and formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Cancer breakthrough pain characteristics and responses to treatment at a VA medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Breakthrough pain: definition, prevalence and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Opioid poorly-responsive cancer pain. Part 1: clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

The role of tramadol in cancer pain treatment--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Analgesic Effect of Auricular Acupuncture for Cancer Pain: A Randomized, Blinded, Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Acute pulmonary embolism: part II: treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Positron emission tomography for prostate, bladder, and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Cryosurgical ablation of soft tissue sarcomas: a phase I trial of feasibility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Results in surgery for primary and metastatic chest wall tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Surgery for solitary metastases of the spine: rationale and results of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Staged stereotactic irradiation for acoustic neuroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Immune response after influenza vaccination in children with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Response to influenza immunisation during treatment for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Influenza immunization of children with neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

Influenza vaccine antibody responses in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

CASE 2. Osteonecrosis of the Jaws Associated With Bisphosphonate Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06829.X

10.1111/J.1464-410X.2007.06829.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference